Pulsed Acoustic Cellular Expression (PACE) is the proprietary form of extracorporeal shock wave technology (ESWT). It utilises high-energy acoustic pressure waves in the shock wave spectrum to produce compressive and tensile stresses on cells and tissue structures to elicit a series of biological responses.

Extracorporeal Shock Wave Technology with PACE

dermaPACE procedures are based on high-energy extracorporeal shock wave technology created through an electrohydraulic method via a procedure console and hand-held applicator.

dermaPACE indications include:

  • Diabetic foot ulcers
  • Arterial leg ulcer
  • Venous leg ulcer
  • Pressure ulcers (decubitus ulcer)
  • Burns
  • Post-operative or traumatic wounds

Download a copy of the Pivotal Phase 3 Trial